Long-term effects of ranibizumab treatment delay in neovascular age-related macular degeneration (Q84099374)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573410 AND SRC:MED&resulttype=core&format=json

1 February 2020

title

Long-term effects of ranibizumab treatment delay in neovascular age-related macular degeneration (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573410 AND SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

Philipp S Muether

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573410 AND SRC:MED&resulttype=core&format=json

1 February 2020

Robert Hoerster

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573410 AND SRC:MED&resulttype=core&format=json

1 February 2020

Manuel M Hermann

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573410 AND SRC:MED&resulttype=core&format=json

1 February 2020

Bernd Kirchhof

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573410 AND SRC:MED&resulttype=core&format=json

1 February 2020

Sascha Fauser

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573410 AND SRC:MED&resulttype=core&format=json

1 February 2020

publication date

11 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573410 AND SRC:MED&resulttype=core&format=json

Graefe's Archive for Clinical and Experimental Ophthalmology

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573410 AND SRC:MED&resulttype=core&format=json

1 February 2020

volume

251

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573410 AND SRC:MED&resulttype=core&format=json

1 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573410 AND SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

453-458

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22573410 AND SRC:MED&resulttype=core&format=json

A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study

1 February 2020

cites work

1 reference

12 December 2020

Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration.

1 reference

12 December 2020

Results of flexible ranibizumab treatment in age-related macular degeneration and search for parameters with impact on outcome.

1 reference

12 December 2020

Long-term visual course after anti-VEGF therapy for exudative AMD in clinical practice evaluation of the German reinjection scheme

1 reference

12 December 2020

Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1

1 reference

12 December 2020

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

1 reference

12 December 2020

Ranibizumab for neovascular age-related macular degeneration

1 reference

12 December 2020

Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: the second year of a prospective study.

1 reference

12 December 2020

Delay between medical indication to anti-VEGF treatment in age-related macular degeneration can result in a loss of visual acuity

1 reference

12 December 2020